Thermal Shift Assay for Ligand Binding in Crude Samples
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting protein-ligand binding interactions are limited, particularly in non-purified samples, as they require purified proteins and cannot effectively measure interactions in complex biological environments, such as cells or tissues, which hinders the prediction of drug efficacy and leads to issues like drug resistance.
Innovation Solution
A thermal shift assay that can detect ligand binding in non-purified samples by separating soluble from insoluble proteins after heat treatment, using affinity reagents to distinguish between folded and denatured proteins, allowing for the analysis of thermal stability without the need for protein purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If purified proteins are used for detecting ligand binding, then measurement precision is improved, but device complexity and ease of operation worsen due to required purification steps
Solution Approach 1:
The patent extracts the detection function from purified protein systems and applies it to crude lysate samples. By using thermal shift assay with temperature-dependent solubility changes, the method isolates the binding detection capability without requiring protein purification steps, thereby maintaining measurement precision while eliminating complex purification procedures
Solution Approach 2:
The thermal shift assay methodology serves multiple functions: it detects ligand binding, determines protein solubility states, and identifies binding partners simultaneously in crude samples. This universal approach works across different protein types and sample preparations without requiring method optimization for each specific case, reducing overall device and process complexity
2Measurement precision
If purified proteins are used for detecting ligand binding, then measurement precision is improved, but productivity worsens due to time-consuming purification steps
Solution Approach 1:
The patent performs preliminary actions by preparing crude lysates in advance without purification, and uses thermal shift assay to directly detect binding events. This eliminates the need for time-consuming purification steps immediately before each binding assay, significantly increasing screening throughput while maintaining detection precision through temperature-dependent solubility measurements
Solution Approach 2:
The methodology skips the entire protein purification process and rushes directly from lysate preparation to binding detection using thermal shift assay. This approach rushes through what would traditionally be a slow, multi-step purification process, thereby dramatically improving productivity and screening capacity without sacrificing measurement accuracy
3Ease of operation
If non-purified samples are analyzed, then ease of operation is improved, but measurement precision worsens due to complex biological environments
Solution Approach 1:
The patent changes the physical parameter of temperature to exploit thermal-dependent solubility differences. By heating the sample, ligand-bound proteins remain soluble while unbound proteins precipitate, creating a clear physical distinction that enables precise binding detection in crude samples. This parameter change transforms a complex biological mixture into a separable system based on thermal properties
Solution Approach 2:
The methodology exploits phase transitions of proteins at different temperatures - specifically the transition from soluble to insoluble state. Ligand-bound proteins undergo a phase transition at higher temperatures compared to unbound proteins, allowing precise detection of binding events through temperature-controlled solubility changes in crude samples without interference from other sample components
4Measurement precision
If thermal shift assay with separation step is used, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent replaces complex mechanical separation systems with a simple thermal treatment approach. Instead of using sophisticated chromatography or centrifugation equipment, the method uses temperature-controlled phase transitions to separate bound from unbound proteins, followed by simple filtration or centrifugation. This mechanical substitution dramatically reduces device complexity while maintaining measurement precision
Solution Approach 2:
The separation mechanism relies on phase transitions of proteins based on their thermal stability. Ligand-bound proteins remain in the soluble phase at elevated temperatures while unbound proteins transition to the insoluble phase. This natural phase separation eliminates the need for complex separation apparatus, requiring only simple filtration or low-speed centrifugation to achieve precise separation and detection
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the detection of ligand binding in complex samples, providing a predictive tool for drug efficacy and resistance, facilitating the development of targeted therapies by assessing drug-target interactions directly in biological samples.
Implementation Method 1
heating the non-purified target protein and ligand to a temperature which is capable of causing or enhancing precipitation of the target protein
Implementation Method 2
a detection method capable of distinguishing between soluble (e.g. folded or native) and denatured (unfolded) proteins (e.g. insoluble proteins) after heat treatment, e.g. a detection method based on the use of a pair of affinity reagents, such as antibodies
Data Source
AI summary
The present invention concerns a method of determining whether a non-purified sample contains a target protein bound to a ligand of interest comprising the steps of a) exposing the non-purified sample to a temperature which is capable of causing or enhancing precipitation of the unbound target protein to a greater extent than it is capable of causing or enhancing precipitation of the target protein bound to the ligand; and b) analyzing said sample for the presence of soluble or native target protein using two or more affinity reagents capable of binding to said soluble or native target protein with a higher affinity than to an unfolded and/or insoluble form of said target protein. The invention particularly concerns the use of two affinity reagents (e.g. antibodies) which are capable of distinguishing between soluble or native, and unfolded and/or insoluble forms of a target protein and whose detection e.g. by FRET based technology, allows the performance of the method without a separation step.